NCT02397408View on ClinicalTrials.gov

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 9, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Prostate Cancer
Interventions
DRUG

Carbon C 11 Choline

Given intravenously (IV) prior to imaging

DRUG

Fluorine F 18 Choline

Given intravenously (IV) prior to imaging

PROCEDURE

Positron Emission Tomography (PET) / Magnetic Resonance Imaging (MRI)

Undergo whole-body PET/MR imaging

Trial Locations (1)

94158

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT02397408 - 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer | Biotech Hunter | Biotech Hunter